Cutting-Edge Technology for
Sustainable Growth

IOI Palm Biotech Sdn Bhd, a BioNexus Status Company, was incorporated on 19 August 2009 as a wholly owned subsidiary of IOI Corporation Berhad. It is established for the main mission to commercially produce superior high-yielding oil palm clones using cutting-edge tissue culture technology developed through in-house research and development since the late 80s. In addition, it also conducts molecular markers and genomics research for continuous improvement in terms of the yield and quality of oil palm planting materials as part of IOI’s sustainable palm oil production value chain.

IOI Palm Biotech’s vision is to be a leading innovative biotechnology company in developing and utilising cutting-edge technologies to add value as well as to improve the oil palm planting materials, which will contribute towards a sustainable financial growth and returns to the company and the palm oil industry.

To date, millions of high-yielding clonal palms have been produced from our purpose-designed tissue culture laboratory. These superior clones are planted in our estates, resulting in higher oil yield and oil extraction rate (OER). The clonal palms form 10% to 50% of oil palm planting in estate groups located in Peninsular Malaysia and Sabah.

Our palm oil mills that received crops from estates planted with 30% to 50% of clones have been consistently reporting an average of ≥24% OER, compared with the industry’s average of 20%.

We expect the OER to continue to increase in the future as more of these clonal palms are being replanted yearly, and more of these come into maturity and reach prime production age.